109 related articles for article (PubMed ID: 3948301)
1. The effect of disulfiram on cyclophosphamide-mediated myeloid toxicity.
Gamelli RL; Ershler WB; Hacker MP; Foster RS
Cancer Chemother Pharmacol; 1986; 16(2):153-5. PubMed ID: 3948301
[TBL] [Abstract][Full Text] [Related]
2. The effects of acetaldophosphamide, a novel stable aldophosphamide analogue, on normal human and leukemic progenitor cells in vitro: implications for use in bone marrow purging.
Beran M; Andersson BS; Wang Y; McCredie KB; Farquhar D
Cancer Res; 1988 Jan; 48(2):339-45. PubMed ID: 3275495
[TBL] [Abstract][Full Text] [Related]
3. Effects of recombinant murine granulocyte-macrophage colony-stimulating factor in cyclophosphamide-treated mice.
Gamba-Vitalo C; DiGiovanna MP; Sartorelli AC
Blood Cells; 1991; 17(1):193-205; discussion 206-8. PubMed ID: 2018856
[TBL] [Abstract][Full Text] [Related]
4. Modification of cyclophosphamide-induced urotoxicity by buthionine sulfoximine and disulfiram in mice.
Ishikawa M; Takayanagi Y; Sasaki K
Res Commun Chem Pathol Pharmacol; 1989 Aug; 65(2):265-8. PubMed ID: 2587846
[TBL] [Abstract][Full Text] [Related]
5. Influence of pretreatment with disulfiram (DSF) on the acute toxicity of cyclophosphamide (CP) in male Sprague-Dawley rats.
Habs H; Habs M; Schmähl D
Arzneimittelforschung; 1981; 31(3):530-1. PubMed ID: 7194679
[TBL] [Abstract][Full Text] [Related]
6. Correlation of antitumor chemoimmunotherapy with bone marrow macrophage precursor cell stimulation and macrophage cytotoxicity.
Fisher B; Wolmark N
Cancer Res; 1976 Jul; 36(7 PT 1):2241-7. PubMed ID: 1277129
[TBL] [Abstract][Full Text] [Related]
7. Drug interaction effects on antitumour drugs (XV): Disulfiram as protective agent against cyclophosphamide-induced urotoxicity without compromising antitumour activity in mice.
Ishikawa M; Aoki T; Yomogida S; Takayanagi Y; Sasaki K
Pharmacol Toxicol; 1994; 74(4-5):255-61. PubMed ID: 8090696
[TBL] [Abstract][Full Text] [Related]
8. Verapamil enhances antitumor activity without increasing myeloid toxicity.
Morrow M; Wait RB; Rosenthal RA; Gamelli RL
Surgery; 1987 Jan; 101(1):63-8. PubMed ID: 3798329
[TBL] [Abstract][Full Text] [Related]
9. Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update.
Peters RH; Brandon CS; Avila LA; Gale GR; Stuart RK
Prog Clin Biol Res; 1990; 333():57-68. PubMed ID: 2309001
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic toxicity by cimetidine. Reexamination using the antimetabolite azathioprine.
Gamelli RL; Foster RS; Whisnant JK
Transplantation; 1983 Jan; 35(1):12-4. PubMed ID: 6823692
[TBL] [Abstract][Full Text] [Related]
11. Effects of cyclophosphamide on murine bone marrow and splenic megakaryocyte-CFC, granulocyte-macrophage-CFC, and peripheral blood cell levels.
Yeager AM; Levin FC; Levin J
J Cell Physiol; 1982 Aug; 112(2):222-8. PubMed ID: 7119022
[TBL] [Abstract][Full Text] [Related]
12. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effects of disulfiram, an alcohol-aversive agent with anti-cancer activity, on mouse bone marrow cells.
Park SR; Joo HG
Korean J Physiol Pharmacol; 2022 May; 26(3):157-164. PubMed ID: 35477543
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal.
van Os R; Robinson S; Sheridan T; Mauch PM
Stem Cells; 2000; 18(2):120-7. PubMed ID: 10742384
[TBL] [Abstract][Full Text] [Related]
15. Effects of protein-calorie malnutrition and refeeding on fluorouracil toxicity.
Gamelli RL; Foster RS
Arch Surg; 1983 Oct; 118(10):1182-5. PubMed ID: 6412659
[TBL] [Abstract][Full Text] [Related]
16. Effects of cadmium on haemopoiesis in irradiated and non-irradiated mice: 1. Relationship to the number of myeloid progenitor cells.
Fedorocko P; Domonkosová A; Kundrátová T; Macková NO; Brezáni P; Fedorocková A
Physiol Res; 1996; 45(2):93-100. PubMed ID: 9496757
[TBL] [Abstract][Full Text] [Related]
17. Myelopoiesis following phorbol ester exposure in human long-term bone marrow cell culture.
Gerson SL; Cooper RA
Leuk Res; 1984; 8(5):791-800. PubMed ID: 6333563
[TBL] [Abstract][Full Text] [Related]
18. Acute and long-term alterations in the granulocyte/macrophage progenitor cell (GM-CFC) compartment of dogs after partial-body irradiation: irradiation of the upper body with a single myeloablative dose.
Nothdurft W; Calvo W; Klinnert V; Steinbach KH; Werner C; Fliedner TM
Int J Radiat Oncol Biol Phys; 1986 Jun; 12(6):949-57. PubMed ID: 3721936
[TBL] [Abstract][Full Text] [Related]
19. Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients.
Talpaz M; Spitzer G; Hittelman W; Kantarjian H; Gutterman J
Exp Hematol; 1986 Aug; 14(7):668-71. PubMed ID: 3460811
[TBL] [Abstract][Full Text] [Related]
20. Effect of disulfiram (tetraethylthiuram disulfide) amd diethyldithiocarbamate on the bladder toxicity and antitumor activity of cyclophosphamide in mice.
Hacker MP; Ershler WB; Newman RA; Gamelli RL
Cancer Res; 1982 Nov; 42(11):4490-4. PubMed ID: 6290038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
